53 results
424B3
PASG
Passage Bio Inc
14 May 24
Prospectus supplement
8:15am
and manufacturing capabilities and strategy, our expectations about the willingness of healthcare professionals to use our product candidates, the sufficiency … regulatory approvals, the clinical utility of our product candidates, our commercialization, marketing and manufacturing capabilities and strategy, our
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
utility of our product candidates, our commercialization, marketing and manufacturing capabilities and strategy, our expectations about the willingness
8-K
EX-99.1
s99kf68gf1en9dgs k3
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
3maxy56 h0e0b
20 Jul 23
Departure of Directors or Certain Officers
7:00am
PRE 14A
vge32dq e31c9z
3 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.2
wzaqgr f0ersldkmb
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.1
d3l ovq10
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
5kp0qvz8si1hhebm3
11 Oct 22
Departure of Directors or Certain Officers
7:15am
8-K
EX-99.2
v5qth2i3sc448
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
9cbnbej73s2h0fi7yeb
1 Jun 22
Departure of Directors or Certain Officers
8:00am